Radiation therapy is a treatment that uses high doses of radiation to damage cancer cells, either killing them or slowing their growth. Unlike the low-dose radiation used in X-rays to see inside the ...

When most people hear “radiation” as a method of treating cancer, they think of external beam radiation therapy, which comes from a machine that aims radiation at the cancer. However, new, targeted ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Re-irradiation of locally recurrent prostate cancer following primary external beam radiation therapy is associated with favorable outcomes. Salvage re-irradiation for locally recurrent prostate ...

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer Men with prostate cancer stage cT1c-T2bN0M0, ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Doctors may use radiation therapy to treat benign tumors. Radiation can shrink and eliminate benign growths without doctors having to perform surgery. Benign tumors are noncancerous growths that can ...

Cherenkov radiation, the faint blue glow produced when charged particles exceed the phase velocity of light in a dielectric medium, has rapidly evolved from a fundamental physical phenomenon to a ...

The risk for biochemical recurrence of prostate cancer after external beam radiation therapy varies by prostate cancer risk category. Investigators who studied men who underwent primary external beam ...

Doctors sometimes use radiation therapy to treat early stage non-Hodgkin’s lymphoma (NHL). To treat advanced stages, they may recommend radiation therapy alongside other treatments, such as ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...